G. TEKGÖL UZUNER Et Al. , "2-Year follow-up data of multiple sclerosis patients treated with cladribine: a single center, a real world study," MULTIPLE SCLEROSIS JOURNAL , no.3, pp.1114-1115, 2024
TEKGÖL UZUNER, G. Et Al. 2024. 2-Year follow-up data of multiple sclerosis patients treated with cladribine: a single center, a real world study. MULTIPLE SCLEROSIS JOURNAL , no.3 , 1114-1115.
TEKGÖL UZUNER, G., ÇELİKELOĞLU, E., & UZUNER, N., (2024). 2-Year follow-up data of multiple sclerosis patients treated with cladribine: a single center, a real world study. MULTIPLE SCLEROSIS JOURNAL , no.3, 1114-1115.
TEKGÖL UZUNER, GÜLNUR, ELİFNUR ÇELİKELOĞLU, And NEVZAT UZUNER. "2-Year follow-up data of multiple sclerosis patients treated with cladribine: a single center, a real world study," MULTIPLE SCLEROSIS JOURNAL , no.3, 1114-1115, 2024
TEKGÖL UZUNER, GÜLNUR T. Et Al. "2-Year follow-up data of multiple sclerosis patients treated with cladribine: a single center, a real world study." MULTIPLE SCLEROSIS JOURNAL , no.3, pp.1114-1115, 2024
TEKGÖL UZUNER, G. ÇELİKELOĞLU, E. And UZUNER, N. (2024) . "2-Year follow-up data of multiple sclerosis patients treated with cladribine: a single center, a real world study." MULTIPLE SCLEROSIS JOURNAL , no.3, pp.1114-1115.
@article{article, author={GÜLNUR TEKGÖL UZUNER Et Al. }, title={2-Year follow-up data of multiple sclerosis patients treated with cladribine: a single center, a real world study}, journal={MULTIPLE SCLEROSIS JOURNAL}, year=2024, pages={1114-1115} }